1. |
OCEBM Levels of Evidence Working Group. The Oxford levels of evidence 2.
|
2. |
Nikles J, Mitchell G, McKinlay L, et al. A series of n-of-1 trials of stimulants in brain injured children. NeuroRehabilitation, 2017, 40(1): 11-21.
|
3. |
Zucker DR, Ruthazer R, Schmid CH. Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J Clin Epidemiol, 2010, 63(12): 1312-1323.
|
4. |
陈新林, 黄海茵, 张长荣, 等. 2015版CENT声明简介: 单病例随机对照试验报告指南. 中国循证医学杂志, 2016, 16(7): 860-863.
|
5. |
翟静波, 商洪才, 李江, 等. 单病例随机对照试验的统计分析方法. 中国循证医学杂志, 2017, 17(4): 494-496.
|
6. |
于大君, 翁维良, 陆芳, 等. 慢性肾脏病Ⅲ期单病例随机对照临床试验. 中医杂志, 2012, 53(3): 222-224.
|
7. |
张昕, 黄李法, 李徐. 高血压脑出血术后患者单病例随机对照临床试验. 浙江中医药大学学报, 2012, 36(8): 871-873,886.
|
8. |
Yuhong H, Qian L, Yu L, et al. An n-of-1 trial service in clinical practice: testing the effectiveness of Liuwei Dihuang decoction for kidney-Yin deficiency syndrome. Evid Based Complement Alternat Med, 2013, 2013: 827915.
|
9. |
Huang H, Yang P, Xue J, et al. Evaluating the individualized treatment of traditional Chinese medicine: a pilot study of N-of-1 trials. Evid Based Complement Alternat Med, 2014, 2014: 148730.
|
10. |
成人支气管扩张症诊治专家共识编写组. 成人支气管扩张症诊治专家共识. 中华结核和呼吸杂志, 2012, 35(7): 485-492.
|
11. |
黄海茵, 杨佩兰, 汤杰, 等. 扶正化痰清热法治疗支气管扩张症46例远期疗效观察. 中医杂志, 2012, 53(10): 848-852.
|
12. |
Huang H, Yang P, Wang J, et al. Investigation into the individualized treatment of traditional Chinese medicine through a series of N-of-1 trials. Evid Based Complement Alternat Med, 2018, 2018: 5813767.
|
13. |
Lu L, An J, Chen H, et al. A series of N-of-1 trials for traditional Chinese medicine using a Bayesian method: study rationale and protocol. Evid Based Complement Alternat Med, 2021, 2021: 9976770.
|
14. |
Huang H, An J, Lu L, et al. Methodological considerations in N-of-1 trials of traditional Chinese medicine. Evid Based Complement Alternat Med, 2021, 2021: 6634134.
|
15. |
Zucker DR, Schmid CH, McIntosh MW, et al. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol, 1997, 50(4): 401-410.
|
16. |
陈新林, 李海文, 刘凤斌, 等. 单病例随机对照试验的设计和评价方法. 中国循证医学杂志, 2016, 16(2): 242-245.
|
17. |
Chen X, Chen P. A comparison of four methods for the analysis of N-of-1 trials. PLoS One, 2014, 9(2): e87752.
|
18. |
陈新林, 刘凤斌, 赵菲, 等. 探索适合中医药N-of-1试验的设计方案及模型. 广州中医药大学学报, 2018, 35(1): 172-175.
|
19. |
Shamseer L, Sampson M, Bukutu C, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. BMJ, 2015, 350: h1793.
|
20. |
Guyatt G, Rennie D. Users' guides to the medical literature: essentials of evidence-based clinical practice (2nd edition). Chicago: American Medical Association Press, 2002: 3-11.
|
21. |
Guyatt GH, Keller JL, Jaeschke R, et al. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med, 1990, 112(4): 293-299.
|
22. |
Polverino E, Goeminne PC, McDonnell MJ, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J, 2017, 50(3): 1700629.
|
23. |
国家中医药管理局. 中医病症诊断疗效标准. 南京: 南京大学出版社, 1994.
|
24. |
张惠勇, 李欣, 倪伟, 等. 支气管扩张证中医辨证分型规律的研究. 上海中医药杂志, 2005, 39(1): 16-18.
|
25. |
陈敏, 黄宁静, 王祎晟. 泻火止痛方治疗肝火上炎型偏头痛的临床研究. 中西医结合心脑血管病杂志, 2015, 13(12): 1375-1377.
|
26. |
Guyatt G, Sackett D, Adachi J, et al. A clinician’s guide for conduction randomized trials in individual patients. CAMJ, 1988, 13(139): 497-503.
|
27. |
Lee BY, Lee S, Lee JS, et al. Validity and reliability of CAT and dyspnea-12 in bronchiectasis and tuberculous destroyed lung. Tuberc Respir Dis (Seoul), 2012, 72(6): 467-474.
|
28. |
郑筱萸. 中药新药临床研究指导原则. 北京: 中国医药科技出版社, 2002.
|
29. |
武胜萍, 徐立鹏, 郭宇, 等. 中国近30年临床研究中安慰剂的应用现状. 中国中药杂志, 2015, 40(7): 1410-1414.
|
30. |
Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. a multicentre, prospective study. Thorax, 2011, 66(5): 425-429.
|
31. |
Senior HE, Mitchell GK, Nikles J, et al. Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol. BMC Palliat Care, 2013, 12(1): 17.
|